IART

Integra Lifesciences Holdings Stock Analysis

AI Rating

Low
  • Quality2/10
  • Growth↓ 2/10
  • Value↓ 1/10
Integra Lifesciences Holdings sales and earnings growth
IART Growth
Fair
  • Revenue Y/Y↓ 0.37%
  • EPS Y/Y↓ -1600.00%
  • FCF Y/Y↑ 126.32%
Integra Lifesciences Holdings gross and profit margin trends
IART Profitability
Fair
  • Gross margin ↑ 51.90%
  • EPS margin↓ -30.10%
  • ROIC 5Y↓ -2.88%
Integra Lifesciences Holdings net debt vs free cash flow
IART Risk
Good
  • Debt / Equity↓ 2.0
  • Debt / FCF↑ 441.8
  • Interest coverage↓ -5.0

Integra Lifesciences Holdings stock volatility is in-line with the overall market. We give it a Good risk rating.

↗ More Medical Devices stocks